Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of ALIF-B.ST is 212 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell